A Clinical Study of YL205 in Patients With Advanced Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Clinical Study of YL205 in Patients With Advanced Solid Tumors	Advanced Solid Tumors	Recruiting	Phase 1 / Phase 2	2025-12-23		NCT06459973

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
MediLink Therapeutics (Suzhou) Co., Ltd.	24

43 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Anyang Cancer Hospital	Anyang	China	11
Central hospital affiliated to Shandong first medical university	Jinan	China	8
Chinese People's Liberation Army Army Characterstic Medical Center	Chongqing	China	1
ChongQing Cancer Hospital	Chongqing	China	14
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley	Las Vegas	United States	3
Florida Cancer Specialists - Lake Mary	Lake Mary	United States	1
Fujian Provincial Cancer Hospital	Fuzhou	China	10
Guangxi Medical University Cancer Hospital	Nanning	China	24
Hainan General Hospital	Haikou	China	10
Harbin Medical University Cancer Hospital	Harbin	China	51
Henan Cancer Hospital	Zhengzhou	China	98
Hubei Cancer Hospital	Wuhan	China	32
Hunan Provincial Cancer Hospital	Changsha	China	1
Jilin Provincial Cancer Hospital	Changchun	China	2
Jingzhou First People's Hospital	Jingzhou	China	4
Liaoning Cancer Hospital	Shenyang	China	15
Linyi Cancer Hospital	Linyi	China	22
Norton Cancer Institute	Louisville	United States	8
Obstetrics & Gynecology Hospital of Fudan University	Shanghai	China	5
Peking Union Medical College Hospital	Beijing	China	112
Providence Cancer Institute - Franz Clinic	Portland	United States	2
Qilu Hospital of Shandong University	Jinan	China	68
Sarah Cannon Research (SCRI)-Tennessee	Nashville	United States	1
Sarah Cannon Research Institute (SCRI)- Denver	Denver	United States	1
Shandong Cancer Hospital	Jinan	China	31

Clinical trials